SCHEMBL496380

SCHEMBL496380

CN(C[C@H](O)[C@H](N)Cc1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALPI P09923 1/20 0.46
PKM P14618 1/20 0.46
PTGS1 P23219 1/20 0.46
XIAP P98170 1/20 0.46
SLC7A5 Q01650 1/20 0.46
LAP3 P28838 3/20 0.45
ANPEP P15144 1/20 0.45
RNPEP Q9H4A4 1/20 0.45
DNPEP Q9ULA0 1/20 0.45
SLC15A1 P46059 1/20 0.44
SPPL2A Q8TCT8 1/20 0.44
HPGD P15428 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
MDM2 Q00987 1/20 0.41
MAOA P21397 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL496342 0.99 CSNK1E (0.46) CSNK1EMEN1KMT2AALPIPKM
SCHEMBL5106607 0.85 CSNK1E (0.49) CSNK1EALPIPKMPTGS1XIAP
Hydrochloric Acid SCHEMBL497143 0.84 CSNK1E (0.48) CSNK1EALPIPKMPTGS1XIAP
SCHEMBL496237 0.80 CSNK1E (0.55) CSNK1ELAP3ANPEPRNPEPDNPEP
SCHEMBL26941825 0.79 CSNK1E (0.51) CSNK1EALPIPKMPTGS1XIAP
SCHEMBL8268266 0.79 CSNK1E (0.43) CSNK1EALPIPKMPTGS1XIAP
SCHEMBL13219388 0.79 CSNK1E (0.43) CSNK1EALPIPKMPTGS1XIAP
Hydrochloric Acid SCHEMBL496260 0.79 CSNK1E (0.54) CSNK1ELAP3ANPEPRNPEPDNPEP
Hydrochloric Acid SCHEMBL15062952 0.79 CSNK1E (0.54) CSNK1ELAP3ANPEPRNPEPDNPEP
Hydrochloric Acid SCHEMBL4789127 0.79 CSNK1E (0.54) CSNK1ELAP3ANPEPRNPEPDNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910317-B1 1-AMINO LINKED COMPOUNDS LILLY CO ELI (US) 2013-07-03 EP disclosed
EP-1910317-B1 1-AMINO LINKED COMPOUNDS LILLY CO ELI (US) 2013-07-03 EP disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed
WO-2007015805-A1 1-AMINO LINKED COMPOUNDS ELI LILLY AND COMPANY (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207735-A1 1-Amino Linked Compounds DPP4, DPP3, DPP9 CSNK1E 194/4885MEN1 3551/4885KMT2A 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.